Aviva is proud to introduce our latest innovation in the field of TB diagnostics - TB Base. As a leading supplier and manufacturer of medical equipment in China, our state-of-the-art factory has produced a cutting-edge platform that streamlines TB testing and analysis processes.
TB Base offers unmatched sensitivity and specificity, enabling accurate and efficient detection of TB in various samples, from sputum to blood. Its user-friendly interface combined with a sophisticated algorithm ensures reliable results and reduced turnaround time, improving patient outcomes.
We understand the COVID-19 pandemic has highlighted the growing importance of disease detection and management, and we are confident that our TB Base platform can contribute significantly to TB eradication efforts globally. As a socially responsible company, Aviva is committed to advancing public health and wellbeing, and we believe TB Base is a crucial component in achieving this goal.